| ［1］ Smith J, ReidyLagunes D. The management of extrapulmonary poorly differentiated (highgrade) neuroendocrine carcinomas［J］. Semin Oncol, 2013, 40(1):100-108. ［2］ Strosberg JR, Coppola D, Klimstra DS, et al. The NANETS consensus guidelines for the diagnosis and management of poorly differentiated (highgrade) extrapulmonary neuroendocrine carcinomas［J］. Pancreas, 2010, 39(6):799-800. ［3］ Dumitrascu T, Dima S, Herlea V, et al. Neuroendocrine tumours of the ampulla of Vater: clinicopathologic al features, surgical approach and assessment of prognosis［J］. Langenbecks Arch Surg, 2012, 397(6):933-943. ［4］ Winter JM, Cameron JL, Olino K, et al. Clinicopathologic analysis of ampullary neoplasms in 450 patients: implications for surgical strategy and longterm prognosis［J］. J Gastrointest Surg, 2010, 14(2):379-387. ［5］ 李增山, 李青. 2010年版消化系统肿瘤WHO分类解读［J］. 中华病理学杂志, 2011, 40(5):351-354. ［6］ AlboresSaavedra J, Hart A, ChabléMontero F, et al. Carcinoids and highgrade neuroendocrine carcinoma of the ampulla of vater: a camparitive analysis of 139 caese from the surveillance, epidemiology, and end results programa population based study［J］. Arch Pathol Lab Med, 2010, 134(11):1692-1696. ［7］ Jayant M, Punia R, Kaushik R, et al. Neuroendocrine tumors of the ampulla of vater: presentation, pathology and prognosis［J］. JOP, 2012, 13(3):263-267. ［8］ Dhir V, Joshi N, Vivekanandarajah S, et al. Recurrent acute pancreatitis in a patient with wirsungocele and neuroendocrine tumor of ampulla of Vater［J］. JOP, 2013, 14(1):99-101. ［9］ Kim J, Lee WJ, Lee SH, et al. Clinical features of 20 patients with curatively resected biliary neuroendocrine tumours［J］. Dig Liver Dis, 2011, 43(12):965-970. ［10］ Salmi S, Ezzedine S, Vitton V, et al. Can papillary carcinomas be treated by endoscopic ampullectomy?［J］. Surg Endosc, 2012, 26(4):920-925. ［11］ Selvakumar E, Rajendran S, Balachandar TG, et al. Neuroendocrine carcinoma of the ampulla of Vater：a clinicopathologic evaluation［J］. Hepatobiliary Panercat Dis Int, 2008, 7(4):422-425. ［12］ Beggs RE, Kelly ME, Eltayeb O, et al. Large cell neuroendocrine carcinoma of the ampulla of Vater［J］. JOP, 2012, 13(5):470-475. ［13］ Ramella Munhoz R, de Mendona Rego JF, de Celis Ferrari AR, et al. Combination of irinotecan and a platinum agent for poorly differentiated neuroendocrine carcinomas［J］. Rare Tumors, 2013, 5(3):e39. ［14］ Frilling A, Sotiropoulos GC, Li J, et al. Multimodal management of neuroendocrine liver metastases［J］. HPB (Oxford), 2010, 12(6):361-379. |
